Clinical Trials in Chicago

Showing 3321-3340 of 9,860 trials

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

NCT03583099

A prospective, multicenter study including a cross-section validation to define sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant Chronic Obstructive Pulmonary Disease (COPD), and its impact on clinical care across a broad range of primary care settings in a cluster randomized controlled clinical trial.

Chronic Obstructive Pulmonary Disease (COPD)

Weill Medical College of Cornell University2,004 participantsStarted Oct 2018

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +6 more locations

TERMINATEDPhase 1/22.2 miles

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

NCT03675126

The purpose of this extension study is to evaluate the safety, tolerability, and pharmacokinetics of repeat administrations of SRP-5051 (vesleteplirsen) in participants with Duchenne muscular dystrophy (DMD) who participated in studies of SRP-5051.

Muscular Dystrophy, Duchenne

Sarepta Therapeutics, Inc.15 participantsStarted Dec 2018

Hartford, Connecticut, United States • Gulf Breeze, Florida, United States • Atlanta, Georgia, United States +5 more locations

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

Find Trials by Condition in Chicago

Intervention to Reduce Early (Peanut) Allergy in Children

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

Breast Cancer Index (BCI) Registry

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

International Weight Control Registry

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry